首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1521385

全球心律不整監測設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Arrhythmia Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球心律不整監測設備市場需求預計將從 2023 年的 83.1 億美元達到 2032 年近 158.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.46%。

心律不整監測設備是用於檢測和監測患者異常心律（稱為心律不整）的醫療設備。這些設備旨在透過連接到患者皮膚或植入體內的電極連續或間歇地監測心臟的電活動。這些設備透過向醫療保健提供者提供即時資料以便及時干預和治療，在診斷和管理各種心律不整（包括心房顫動、室性心動過速和心動過緩）方面發揮著不可或缺的作用。

市場動態

由於心血管疾病盛行率上升，加上全球人口老化，心律不整發生率不斷上升，心律不整監測設備市場正經歷快速成長。隨著高血壓、糖尿病和肥胖等危險因子發生率的增加，對能夠準確檢測和監測異常心律的可靠心律不整監測設備的需求也增加。穿戴式監視器、植入式心臟監視器 (ICM) 和行動心臟遙測系統 (MCT) 等技術進步和創新增強了心臟資料連續監測和遠端傳輸的能力。這些技術進步提高了患者的舒適度，能夠及早發現心律不整，並促進醫療保健提供者主動管理心臟病。

此外，向個人化醫療和以病人為中心的護理模式的轉變推動了心律不整監測設備的採用。這些設備使患者能夠透過提供即時心律資料和有關潛在心臟異常的警報來管理他們的醫療保健。增強患者的參與度和對治療方案的依從性有助於改善臨床結果並降低與未診斷或未經治療的心律不整併發症相關的醫療費用。然而，報銷限制和成本限制可能會影響市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心律不整監測設備市場的各個細分市場進行了包容性評估。心律不整監測設備產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

心律不整監測設備市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

心電圖
植入式監視器
動態心電圖監測儀
移動心臟遙測

按申請

心搏過緩
心跳過速
心房震顫
心室顫動
宮縮過早
其他

按最終用途

醫院和診所
診斷中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心律不整監測設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心律不整監測設備市場的主要參與者包括AliveCor Inc.、Applied Cardiac Systems、BioTelemetry Inc.、Biotronik、FU.K.Uda Denshi Co. Ltd.、GE Healthcare、IRhythm、Medi-Lynx、St. Jude Medical (Abbott ) ）、美敦力（Medtronic）、日本光電公司（Nihon Kohden Corporation）、Nuubo、Spacelabs Healthcare。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：心律不整監測設備公司的競爭格局

心律不整監測設備市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
AliveCor Inc.

公司簡介
公司收入
產品
最近的發展

Applied Cardiac Systems

公司簡介
公司收入
產品
最近的發展

BioTelemetry Inc.

公司簡介
公司收入
產品
最近的發展

Biotronik

公司簡介
公司收入
產品
最近的發展

FU.K.Uda Denshi Co. Ltd.

公司簡介
公司收入
產品
最近的發展

GE Healthcare

公司簡介
公司收入
產品
最近的發展

IRhythm

公司簡介
公司收入
產品
最近的發展

Medi-Lynx

公司簡介
公司收入
產品
最近的發展

St. Jude Medical (Abbott)

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

Nihon Kohden Corporation

公司簡介
公司收入
產品
最近的發展

Nuubo

公司簡介
公司收入
產品
最近的發展

Spacelabs Healthcare

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115264

The global demand for Arrhythmia Monitoring Devices Market is presumed to reach the market size of nearly USD 15.87 Billion by 2032 from USD 8.31 Billion in 2023 with a CAGR of 7.46% under the study period 2024-2032.

Arrhythmia monitoring devices are medical devices utilized to detect and monitor abnormal heart rhythms, known as arrhythmias, in patients. These devices are designed to continuously or intermittently monitor the heart's electrical activity through electrodes attached to the patient's skin or implanted within the body. These devices play an integral role in diagnosing and managing various arrhythmias, including atrial fibrillation, ventricular tachycardia, and bradycardia, by providing real-time data to healthcare providers for timely intervention and treatment.

MARKET DYNAMICS

The arrhythmia monitoring devices market is experiencing rapid growth fueled by the rising prevalence of cardiovascular diseases, together with the growing aging population globally, which is contributing to the rising incidence of arrhythmias. As the incidence of risk factors such as hypertension, diabetes, and obesity increases, so does the demand for reliable arrhythmia monitoring devices that can accurately detect and monitor abnormal heart rhythms. Technological advancements and innovations such as wearable monitors, implantable cardiac monitors (ICMs), and mobile cardiac telemetry systems (MCTs) offer enhanced capabilities for continuous monitoring and remote transmission of cardiac data. These technological advancements improve patient comfort, enable early detection of arrhythmias, and facilitate healthcare providers' proactive management of cardiac conditions.

Moreover, the shift towards personalized medicine and patient-centric care models drives the adoption of arrhythmia monitoring devices. These devices enable patients to manage their healthcare by providing real-time heart rhythm data and alerts about potential cardiac abnormalities. Enhanced patient engagement and adherence to treatment regimens contribute to enhanced clinical outcomes and reduced healthcare costs associated with complications from undiagnosed or untreated arrhythmias. However, reimbursement limitations and cost constraints may impact market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Arrhythmia Monitoring Devices. The growth and trends of Arrhythmia Monitoring Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Arrhythmia Monitoring Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

ECG
Implantable Monitors
Holter Monitors
Mobile Cardiac Telemetry

By Application

Bradycardia
Tachycardia
Atrial Fibrillation
Ventricular Fibrillation
Premature Contraction
Others

By End-use

Hospitals & Clinics
Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Arrhythmia Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Arrhythmia Monitoring Devices market include AliveCor Inc., Applied Cardiac Systems, BioTelemetry Inc., Biotronik, FU.K.Uda Denshi Co. Ltd., GE Healthcare, IRhythm, Medi-Lynx, St. Jude Medical (Abbott), Medtronic, Nihon Kohden Corporation, Nuubo, Spacelabs Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ARRHYTHMIA MONITORING DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. ECG Historic and Forecast Sales By Regions
5.4. Implantable Monitors Historic and Forecast Sales By Regions
5.5. Holter Monitors Historic and Forecast Sales By Regions
5.6. Mobile Cardiac Telemetry Historic and Forecast Sales By Regions

6. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Bradycardia Historic and Forecast Sales By Regions
6.4. Tachycardia Historic and Forecast Sales By Regions
6.5. Atrial Fibrillation Historic and Forecast Sales By Regions
6.6. Ventricular Fibrillation Historic and Forecast Sales By Regions
6.7. Premature Contraction Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data Analysis By End-use
7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Diagnostic Centers Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ARRHYTHMIA MONITORING DEVICES COMPANIES

9.1. Arrhythmia Monitoring Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ARRHYTHMIA MONITORING DEVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. AliveCor Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Applied Cardiac Systems
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. BioTelemetry Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Biotronik
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. FU.K.Uda Denshi Co. Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. GE Healthcare
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. IRhythm
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Medi-Lynx
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. St. Jude Medical (Abbott)
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Medtronic
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Nihon Kohden Corporation
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Nuubo
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Spacelabs Healthcare
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments